US Patent

US8476268 — Pyrrolidine-1,2-dicarboxamide derivatives

Composition of Matter · Assigned to Novartis AG · Expires 2029-09-10 · 3y remaining

Vulnerability score 18/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects a compound of formula (I) or a salt thereof, used in the treatment of diseases alleviated by inhibition of phosphatidylinositol 3-kinase.

USPTO Abstract

The present invention relates to a compound of formula (I) or a salt thereof, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.

Drugs covered by this patent

Patent Metadata

Patent number
US8476268
Jurisdiction
US
Classification
Composition of Matter
Expires
2029-09-10
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.